HANGZHOU and SHAOXING, China, Aug. 4, 2019 /PRNewswire/ -- Ascletis Pharma Inc. (1672.HK), an innovative R&D driven, commercial-stage biotechnology company addressing unmet medical needs in therapeutic areas including anti-viral, cancer and fatty liver diseases, announces today that it...
from PR Newswire: https://ift.tt/2YFFkQb
No comments:
Post a Comment